AbCellera Biologics Inc.
NASDAQ:ABCL
Overview | Financials
Company Name | AbCellera Biologics Inc. |
Symbol | ABCL |
Currency | USD |
Price | 2.77 |
Market Cap | 818,163,820 |
Dividend Yield | 0% |
52-week-range | 2.335 - 5.62 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Carl L.G. Hansen Ph.D. |
Website | https://www.abcellera.com |
An error occurred while fetching data.
About AbCellera Biologics Inc.
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD